US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

46.35

-0.5900-1.26%

Post-market: 46.350.00000.00%18:10 EDT

Volume:2.71M

Turnover:126.39M

Market Cap:27.03B

PE:26.02

High:47.33

Open:47.00

Low:46.06

Close:46.94

52wk High:47.86

52wk Low:29.66

Shares:583.17M

Float Shares:379.85M

Volume Ratio:0.64

T/O Rate:0.71%

Dividend:0.88

Dividend Rate:1.90%

EPS(TTM):1.78

EPS(LYR):1.78

ROE:13.20%

ROA:5.15%

PB:4.17

PE(LYR):26.02

Loading ...

Overview Company News Filings

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones

THOMSON REUTERS

PTC Therapeutics Sells Remaining Royalty Interest in Evrysdi to Royalty Pharma for $240 Million

EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

How Investors Are Reacting To Royalty Pharma (RPRX) Expanding Oncology Royalties With Nuvalent Deal

Simply Wall St.

Royalty Pharma - Buys Low-Single Digit Royalty on Neladalkib and Zidesamtinib

THOMSON REUTERS

Royalty Pharma - Royalty Duration for Both Therapies Extends Through 2041 to 2042

THOMSON REUTERS

Royalty Pharma (RPRX): Revisiting Valuation After Fresh Analyst Upgrades and Strengthening Buy-Side Consensus

Simply Wall St.

Royalty Pharma : TD Cowen Raises Target Price to $45 From $42

THOMSON REUTERS

EVP, Investments & CLO George W. Lloyd Reports Disposal of Royalty Pharma plc Common Shares

Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start

Benzinga_recent_news

Denali Therapeutics, Royalty Pharma Enter $275 Million Royalty Funding Agreement for Hunter Syndrome Treatment

Denali Therapeutics Inc - Royalty Pharma to Receive 9.25% Royalty on Worldwide Sales of Tividenofusp Alfa From Denali

THOMSON REUTERS

Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares

Will Raised 2025 Guidance and CFO Share Sale Shift Royalty Pharma's (RPRX) Growth Narrative?

Simply Wall St.

Royalty Pharma CFO Terrance P. Coyne Reports Sale of Common Shares

Royalty Pharma to Present at Citi and Evercore Healthcare Investor Conferences

Royalty Pharma EVP George W. Lloyd Reports Sale of Common Shares

Royalty Pharma plc Publishes Transcript of Q3 2025 Earnings Call

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RPRX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","market":"US","secType":"STK","nameCN":"Royalty Pharma plc","latestPrice":46.35,"timestamp":1774641600000,"preClose":46.94,"halted":0,"volume":2710159,"hourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"delay":0,"changeRate":-0.012569237324243638,"floatShares":379849980,"shares":583174298,"eps":1.781403,"marketStatus":"Market Closed","change":-0.59,"latestTime":"03-27 16:00:00 EDT","open":46.995,"high":47.33,"low":46.06,"amount":126388218.892297,"amplitude":0.027056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.781403,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1592280000000,"exchange":"NASDAQ","adjPreClose":46.94,"dividendRate":0.018986,"preHourTrading":{"tag":"盘前","latestPrice":47.26,"preClose":46.94,"latestTime":"09:20 EDT","volume":7472,"amount":350385.9904,"timestamp":1774617611010,"change":0.32,"changeRate":0.006817,"amplitude":0.01553},"postHourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"volumeRatio":0.640336,"impliedVol":0.3079,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","floatShares":379849980,"roa":"5.15%","roe":"13.20%","lyrEps":1.781403,"volumeRatio":0.640336,"shares":583174298,"dividePrice":0.88,"high":47.33,"amplitude":0.027056,"preClose":46.94,"low":46.06,"week52Low":29.66,"pbRate":"4.17","psRate":"11.37","week52High":47.86,"institutionHeld":0.9297,"latestPrice":46.35,"eps":1.781403,"divideRate":0.018986,"volume":2710159,"delay":0,"ttmEps":1.781403,"open":46.995,"prevYearClose":38.64,"prevWeekClose":45.36,"prevMonthClose":46.21,"prevQuarterClose":38.64,"fiveDayClose":45.36,"twentyDayClose":46.21,"sixtyDayClose":38.99,"dividendPayoutRate":0.4905978045748245,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0.047619047619047665,"fiveYearAvgDividendRate":0.02408439366820899},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRX\",params:#limit:5,,,undefined,":[{"date":"2026-02-20","symbol":"RPRX","amount":0.235,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-10"},{"market":"US","date":"2026-02-11","symbol":"RPRX","fiscalQuarterEnding":"2025/12","expectedEps":1.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"pre","actualEps":1.46},{"date":"2025-11-14","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-10","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-12-10"},{"market":"US","date":"2025-11-05","symbol":"RPRX","fiscalQuarterEnding":"2025/09","expectedEps":1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":1.17},{"date":"2025-08-15","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-10","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRX\",market:\"US\",,,undefined,":[{"executeDate":"2020-09-14","recordDate":"2020-09-15","paymentDate":"2020-09-30","value":0.15,"currency":"USD"},{"executeDate":"2020-11-19","recordDate":"2020-11-20","paymentDate":"2020-12-15","value":0.15,"currency":"USD"},{"executeDate":"2021-02-18","recordDate":"2021-02-19","paymentDate":"2021-03-15","value":0.17,"currency":"USD"},{"executeDate":"2021-05-19","recordDate":"2021-05-20","paymentDate":"2021-06-15","value":0.17,"currency":"USD"},{"executeDate":"2021-08-19","recordDate":"2021-08-20","paymentDate":"2021-09-15","value":0.17,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1770868800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RPRX","date":"2026-03-27","current":26.018818,"percent":0.500407,"low":9.420627,"twenty":15.379534,"median":26.077607,"eighty":56.189678,"high":536.452748,"avg":54.528835,"sd":101.407359,"marketCap":20109969647},"quantilePoints":[{"date":"2021-04-01","current":26.780274,"twenty":10.841764,"median":12.736219,"eighty":14.558244,"marketCap":26111838518},{"date":"2021-04-09","current":26.344418,"twenty":10.870271,"median":12.777628,"eighty":14.859728,"marketCap":25686860909},{"date":"2021-04-16","current":26.070451,"twenty":10.877008,"median":12.890883,"eighty":15.364506,"marketCap":25419732126},{"date":"2021-04-23","current":27.153866,"twenty":10.880637,"median":12.943264,"eighty":25.867466,"marketCap":26476105040},{"date":"2021-04-30","current":27.609843,"twenty":10.889966,"median":13.040871,"eighty":26.105319,"marketCap":26920701720},{"date":"2021-05-07","current":25.708529,"twenty":10.902405,"median":13.112851,"eighty":26.233724,"marketCap":25066844306},{"date":"2021-05-14","current":25.415982,"twenty":10.923137,"median":13.188745,"eighty":26.203698,"marketCap":24727692206},{"date":"2021-05-21","current":25.397262,"twenty":11.006583,"median":13.242152,"eighty":26.105319,"marketCap":24709478831},{"date":"2021-05-28","current":25.035336,"twenty":11.014357,"median":13.396752,"eighty":26.063326,"marketCap":24357353580},{"date":"2021-06-04","current":28.211553,"twenty":11.037163,"median":13.462808,"eighty":26.226114,"marketCap":27447556215},{"date":"2021-06-11","current":28.01811,"twenty":11.073444,"median":13.525947,"eighty":26.468948,"marketCap":27259351339},{"date":"2021-06-18","current":27.46898,"twenty":11.088992,"median":13.552567,"eighty":26.637064,"marketCap":26725092338},{"date":"2021-06-25","current":26.570403,"twenty":11.125544,"median":13.593515,"eighty":26.668197,"marketCap":25850850335},{"date":"2021-07-02","current":26.35824,"twenty":11.210793,"median":13.670814,"eighty":26.643499,"marketCap":25644432084},{"date":"2021-07-09","current":26.064954,"twenty":11.239817,"median":13.722576,"eighty":26.638351,"marketCap":25359089208},{"date":"2021-07-16","current":26.726929,"twenty":11.289271,"median":13.759358,"eighty":26.648439,"marketCap":26003137199},{"date":"2021-07-23","current":26.581925,"twenty":11.338048,"median":13.881632,"eighty":26.679943,"marketCap":25862059759},{"date":"2021-07-30","current":25.17802,"twenty":11.350107,"median":13.916375,"eighty":26.648439,"marketCap":24496173638},{"date":"2021-08-06","current":24.380496,"twenty":11.371465,"median":14.057313,"eighty":26.638351,"marketCap":23720247719},{"date":"2021-08-13","current":24.202628,"twenty":11.413966,"median":14.101803,"eighty":26.627102,"marketCap":23515781358},{"date":"2021-08-20","current":24.371352,"twenty":11.425707,"median":14.162722,"eighty":26.606281,"marketCap":23679717867},{"date":"2021-08-27","current":24.490085,"twenty":11.428044,"median":14.303845,"eighty":26.590141,"marketCap":23795080595},{"date":"2021-09-03","current":24.565073,"twenty":11.442485,"median":14.393216,"eighty":26.58299,"marketCap":23867941265},{"date":"2021-09-10","current":24.046401,"twenty":11.483683,"median":14.412385,"eighty":26.575012,"marketCap":23363988295},{"date":"2021-09-17","current":24.058899,"twenty":11.513281,"median":14.476137,"eighty":26.520738,"marketCap":23376131740},{"date":"2021-09-24","current":23.18403,"twenty":11.53978,"median":14.588573,"eighty":26.47642,"marketCap":22526090586},{"date":"2021-10-01","current":22.640362,"twenty":11.560125,"median":14.847176,"eighty":26.437867,"marketCap":21997850726},{"date":"2021-10-08","current":22.177931,"twenty":11.592778,"median":15.062517,"eighty":26.384717,"marketCap":21548543258},{"date":"2021-10-15","current":23.99016,"twenty":11.640462,"median":15.413014,"eighty":26.360183,"marketCap":23309342792},{"date":"2021-10-22","current":23.433993,"twenty":11.659417,"median":22.124814,"eighty":26.350751,"marketCap":22768959487},{"date":"2021-10-29","current":24.702553,"twenty":11.679854,"median":22.271667,"eighty":26.344954,"marketCap":24001519161},{"date":"2021-11-05","current":24.696304,"twenty":11.723704,"median":22.559124,"eighty":26.333991,"marketCap":23995447438},{"date":"2021-11-12","current":32.51009,"twenty":11.752375,"median":22.640362,"eighty":26.350751,"marketCap":25452734666},{"date":"2021-11-19","current":32.2309,"twenty":11.763977,"median":22.8872,"eighty":26.47642,"marketCap":25234152021},{"date":"2021-11-26","current":32.486824,"twenty":11.775219,"median":22.924694,"eighty":26.585121,"marketCap":25434519446},{"date":"2021-12-03","current":29.19859,"twenty":11.807468,"median":23.015305,"eighty":26.640925,"marketCap":22860101627},{"date":"2021-12-10","current":29.291653,"twenty":11.847383,"median":23.171532,"eighty":26.80037,"marketCap":22932962508},{"date":"2021-12-17","current":29.888809,"twenty":11.870433,"median":23.215276,"eighty":26.895847,"marketCap":23400486499},{"date":"2021-12-23","current":31.21496,"twenty":11.891419,"median":23.371502,"eighty":27.107873,"marketCap":24438754063},{"date":"2021-12-31","current":30.904749,"twenty":11.910529,"median":23.48711,"eighty":27.173363,"marketCap":24195884457},{"date":"2022-01-07","current":31.222715,"twenty":11.93171,"median":23.58397,"eighty":27.251023,"marketCap":24444825803},{"date":"2022-01-14","current":30.757399,"twenty":11.982869,"median":23.843307,"eighty":27.501351,"marketCap":24080521395},{"date":"2022-01-21","current":30.354125,"twenty":12.0166,"median":23.915171,"eighty":27.798092,"marketCap":23764790907},{"date":"2022-01-28","current":30.602294,"twenty":12.025032,"median":23.99016,"eighty":27.981993,"marketCap":23959086592},{"date":"2022-02-04","current":30.997812,"twenty":12.078439,"median":24.05265,"eighty":28.604645,"marketCap":24268745339},{"date":"2022-02-11","current":30.912504,"twenty":12.120603,"median":24.152635,"eighty":28.953331,"marketCap":24201956198},{"date":"2022-02-18","current":38.611798,"twenty":12.199308,"median":24.193255,"eighty":29.097649,"marketCap":23928812189},{"date":"2022-02-25","current":37.690836,"twenty":12.300501,"median":24.209173,"eighty":29.140126,"marketCap":23358066605},{"date":"2022-03-04","current":37.641849,"twenty":12.370773,"median":24.296364,"eighty":29.218581,"marketCap":23327707798},{"date":"2022-03-11","current":37.494887,"twenty":12.393263,"median":24.333858,"eighty":29.372308,"marketCap":23236631375},{"date":"2022-03-18","current":38.523621,"twenty":12.400806,"median":24.371352,"eighty":29.55223,"marketCap":23874166335},{"date":"2022-03-25","current":37.592862,"twenty":12.401989,"median":24.41822,"eighty":29.826979,"marketCap":23297348990},{"date":"2022-04-01","current":38.56281,"twenty":12.415244,"median":24.490085,"eighty":30.011342,"marketCap":23898453382},{"date":"2022-04-08","current":40.581088,"twenty":12.46803,"median":24.558469,"eighty":30.160243,"marketCap":25149236257},{"date":"2022-04-14","current":43.206807,"twenty":12.481269,"median":24.62444,"eighty":30.337063,"marketCap":26776468347},{"date":"2022-04-22","current":41.977613,"twenty":12.531575,"median":24.702553,"eighty":30.374674,"marketCap":26014702030},{"date":"2022-04-29","current":41.717726,"twenty":12.617931,"median":24.768168,"eighty":30.481311,"marketCap":25853642688},{"date":"2022-05-06","current":40.037043,"twenty":12.672923,"median":24.835282,"eighty":30.64107,"marketCap":24117113377},{"date":"2022-05-13","current":40.258799,"twenty":12.697537,"median":24.934608,"eighty":30.867524,"marketCap":24250692555},{"date":"2022-05-20","current":39.835446,"twenty":12.713191,"median":25.066536,"eighty":30.997812,"marketCap":23995677761},{"date":"2022-05-27","current":41.599415,"twenty":12.727345,"median":25.116457,"eighty":31.059854,"marketCap":25058239402},{"date":"2022-06-03","current":40.843428,"twenty":12.733261,"median":25.194498,"eighty":31.165326,"marketCap":24602855842},{"date":"2022-06-10","current":40.803109,"twenty":12.735627,"median":25.334861,"eighty":31.219613,"marketCap":24578568718},{"date":"2022-06-17","current":39.664089,"twenty":12.739177,"median":25.403502,"eighty":31.585662,"marketCap":23892457487},{"date":"2022-06-24","current":43.54482,"twenty":12.746867,"median":25.497104,"eighty":32.196777,"marketCap":26230093099},{"date":"2022-07-01","current":43.081148,"twenty":12.778811,"median":25.671953,"eighty":32.432537,"marketCap":25950791181},{"date":"2022-07-08","current":43.302904,"twenty":12.783544,"median":25.758729,"eighty":32.51009,"marketCap":26084370359},{"date":"2022-07-15","current":44.280647,"twenty":12.872277,"median":25.81215,"eighty":32.913364,"marketCap":26673333098},{"date":"2022-07-22","current":43.575059,"twenty":12.909488,"median":25.883655,"eighty":37.112786,"marketCap":26248308441},{"date":"2022-07-29","current":43.837135,"twenty":12.927331,"median":25.924329,"eighty":37.494887,"marketCap":26406174742},{"date":"2022-08-05","current":55.302721,"twenty":12.943264,"median":26.008185,"eighty":37.641849,"marketCap":25776487684},{"date":"2022-08-12","current":57.582574,"twenty":12.984673,"median":26.031171,"eighty":37.739824,"marketCap":26839122629},{"date":"2022-08-19","current":57.452297,"twenty":13.031997,"median":26.064954,"eighty":37.955368,"marketCap":26778400632},{"date":"2022-08-26","current":56.084385,"twenty":13.049744,"median":26.130056,"eighty":38.170912,"marketCap":26140819665},{"date":"2022-09-02","current":54.807667,"twenty":13.070449,"median":26.166685,"eighty":38.396254,"marketCap":25545744095},{"date":"2022-09-09","current":56.839993,"twenty":13.104371,"median":26.235626,"eighty":38.531459,"marketCap":26493007247},{"date":"2022-09-16","current":54.651334,"twenty":13.130841,"median":26.335729,"eighty":38.654091,"marketCap":25472877699},{"date":"2022-09-23","current":52.540842,"twenty":13.157825,"median":26.35824,"eighty":38.942952,"marketCap":24489181349},{"date":"2022-09-30","current":52.345426,"twenty":13.203924,"median":26.443047,"eighty":39.5308,"marketCap":24398098354},{"date":"2022-10-07","current":53.231312,"twenty":13.220789,"median":26.570403,"eighty":39.868964,"marketCap":24811007933},{"date":"2022-10-14","current":53.947837,"twenty":13.238217,"median":26.594475,"eighty":40.109618,"marketCap":25144978916},{"date":"2022-10-21","current":53.439755,"twenty":13.287126,"median":26.637064,"eighty":40.381773,"marketCap":24908163128},{"date":"2022-10-28","current":55.706581,"twenty":13.343344,"median":26.697563,"eighty":40.596976,"marketCap":25964725874},{"date":"2022-11-04","current":54.638307,"twenty":13.42205,"median":26.813768,"eighty":40.835364,"marketCap":25466805499},{"date":"2022-11-11","current":52.620617,"twenty":13.438915,"median":26.87804,"eighty":41.030913,"marketCap":26669181236},{"date":"2022-11-18","current":51.362611,"twenty":13.477144,"median":26.991976,"eighty":41.419994,"marketCap":26031598351},{"date":"2022-11-25","current":51.494402,"twenty":13.508626,"median":27.128959,"eighty":41.588023,"marketCap":26098392749},{"date":"2022-12-02","current":52.53675,"twenty":13.524865,"median":27.163206,"eighty":41.70117,"marketCap":26626675710},{"date":"2022-12-09","current":50.020737,"twenty":13.531271,"median":27.175694,"eighty":42.099572,"marketCap":25351509941},{"date":"2022-12-16","current":48.175661,"twenty":13.536595,"median":27.242334,"eighty":42.522809,"marketCap":24416388376},{"date":"2022-12-23","current":47.253123,"twenty":13.555525,"median":27.46898,"eighty":42.883467,"marketCap":23948827594},{"date":"2022-12-30","current":47.348971,"twenty":13.573322,"median":27.509444,"eighty":43.081148,"marketCap":23997405338},{"date":"2023-01-06","current":45.635686,"twenty":13.58452,"median":27.609843,"eighty":43.15977,"marketCap":23129078171},{"date":"2023-01-13","current":47.169255,"twenty":13.602481,"median":27.828632,"eighty":43.302904,"marketCap":23906322069},{"date":"2023-01-20","current":45.92323,"twenty":13.638343,"median":27.953974,"eighty":43.369326,"marketCap":23274811402},{"date":"2023-01-27","current":46.606148,"twenty":13.663787,"median":28.075391,"eighty":43.492269,"marketCap":23620927825},{"date":"2023-02-03","current":46.678034,"twenty":13.677842,"median":28.635778,"eighty":43.575059,"marketCap":23657361133},{"date":"2023-02-10","current":45.647667,"twenty":13.700329,"median":28.791441,"eighty":44.018571,"marketCap":23135150389},{"date":"2023-02-17","current":536.452748,"twenty":13.744823,"median":28.985327,"eighty":45.527856,"marketCap":22977344089},{"date":"2023-02-24","current":515.754518,"twenty":13.745207,"median":29.047283,"eighty":45.638082,"marketCap":22090797514},{"date":"2023-03-03","current":505.263634,"twenty":13.756547,"median":29.121037,"eighty":45.865721,"marketCap":21641451990},{"date":"2023-03-10","current":469.254386,"twenty":13.824571,"median":29.181811,"eighty":46.294641,"marketCap":20099103841},{"date":"2023-03-17","current":491.086765,"twenty":13.863361,"median":29.214845,"eighty":46.433622,"marketCap":21034228309},{"date":"2023-03-24","current":502.286492,"twenty":13.889221,"median":29.284382,"eighty":46.639695,"marketCap":21513935017},{"date":"2023-03-31","current":510.792614,"twenty":13.89653,"median":29.384716,"eighty":46.953597,"marketCap":21878269226},{"date":"2023-04-06","current":514.195062,"twenty":13.908662,"median":29.389187,"eighty":46.991936,"marketCap":22024002909},{"date":"2023-04-14","current":517.881048,"twenty":13.930103,"median":29.629008,"eighty":47.183633,"marketCap":22181881066},{"date":"2023-04-21","current":511.926763,"twenty":14.003344,"median":29.811522,"eighty":47.38731,"marketCap":21926847120},{"date":"2023-04-28","current":501.012305,"twenty":14.059562,"median":29.901277,"eighty":48.453621,"marketCap":21459359029},{"date":"2023-05-05","current":494.632691,"twenty":14.081953,"median":30.06718,"eighty":50.15732,"marketCap":21186107429},{"date":"2023-05-12","current":63.132216,"twenty":14.097435,"median":30.121467,"eighty":50.607807,"marketCap":20949289375},{"date":"2023-05-19","current":61.532363,"twenty":14.125705,"median":30.273353,"eighty":51.046312,"marketCap":20418037790},{"date":"2023-05-26","current":58.989098,"twenty":14.148386,"median":30.350248,"eighty":51.427308,"marketCap":19574116514},{"date":"2023-06-02","current":60.690707,"twenty":14.160754,"median":30.36188,"eighty":51.544722,"marketCap":20138754490},{"date":"2023-06-09","current":63.179081,"twenty":14.184848,"median":30.416167,"eighty":52.19192,"marketCap":20964461638},{"date":"2023-06-16","current":58.915911,"twenty":14.243506,"median":30.482087,"eighty":52.539205,"marketCap":19549831009},{"date":"2023-06-23","current":56.738584,"twenty":14.315085,"median":30.602294,"eighty":52.629752,"marketCap":18827337255},{"date":"2023-06-29","current":54.158725,"twenty":14.348803,"median":30.610049,"eighty":52.716465,"marketCap":17971273226},{"date":"2023-07-07","current":55.787147,"twenty":14.368253,"median":30.7225,"eighty":53.147934,"marketCap":18511625698},{"date":"2023-07-14","current":56.189678,"twenty":14.385627,"median":30.817667,"eighty":53.439755,"marketCap":18645195972},{"date":"2023-07-21","current":57.031334,"twenty":14.406989,"median":30.912504,"eighty":53.523133,"marketCap":18924479272},{"date":"2023-07-28","current":56.720287,"twenty":14.411846,"median":30.997812,"eighty":53.911359,"marketCap":18821265879},{"date":"2023-08-04","current":55.970115,"twenty":14.415735,"median":31.028834,"eighty":54.260503,"marketCap":18572339459},{"date":"2023-08-11","current":72.162914,"twenty":14.43566,"median":31.102508,"eighty":54.461129,"marketCap":18397718410},{"date":"2023-08-18","current":69.094161,"twenty":14.479538,"median":31.168428,"eighty":54.648729,"marketCap":17615348965},{"date":"2023-08-25","current":69.778729,"twenty":14.509418,"median":31.203327,"eighty":54.763373,"marketCap":17789877534},{"date":"2023-09-01","current":70.392479,"twenty":14.580141,"median":31.269247,"eighty":54.978425,"marketCap":17946351423},{"date":"2023-09-08","current":68.126323,"twenty":14.602628,"median":31.455373,"eighty":55.107305,"marketCap":17368601679},{"date":"2023-09-15","current":67.890265,"twenty":14.667652,"median":31.928445,"eighty":55.289693,"marketCap":17308419414},{"date":"2023-09-22","current":61.988816,"twenty":14.847176,"median":32.246411,"eighty":55.641442,"marketCap":15803862789},{"date":"2023-09-29","current":63.216318,"twenty":14.859728,"median":32.339474,"eighty":55.973774,"marketCap":16116810567},{"date":"2023-10-06","current":62.767808,"twenty":15.016671,"median":32.482946,"eighty":56.080794,"marketCap":16002464263},{"date":"2023-10-13","current":63.971703,"twenty":15.066953,"median":32.556622,"eighty":56.189678,"marketCap":16309393815},{"date":"2023-10-20","current":66.355888,"twenty":15.150362,"median":32.773769,"eighty":56.544637,"marketCap":16917234691},{"date":"2023-10-27","current":64.32579,"twenty":15.218983,"median":32.928874,"eighty":56.599178,"marketCap":16399667212},{"date":"2023-11-03","current":64.868723,"twenty":16.726003,"median":36.907039,"eighty":56.712968,"marketCap":16538086422},{"date":"2023-11-10","current":88.80003,"twenty":21.996708,"median":37.21566,"eighty":56.826842,"marketCap":16375613449},{"date":"2023-11-17","current":85.949098,"twenty":22.092944,"median":37.494887,"eighty":56.889499,"marketCap":15849873215},{"date":"2023-11-24","current":87.765402,"twenty":22.177931,"median":37.592862,"eighty":57.067927,"marketCap":16184817745},{"date":"2023-12-01","current":65.305922,"twenty":22.190429,"median":37.666342,"eighty":57.217798,"marketCap":12043065075},{"date":"2023-12-08","current":69.407144,"twenty":22.271667,"median":37.730026,"eighty":57.452297,"marketCap":12799371342},{"date":"2023-12-15","current":69.069396,"twenty":22.390399,"median":37.75452,"eighty":57.77799,"marketCap":12737087296},{"date":"2023-12-22","current":66.053792,"twenty":22.540377,"median":37.955368,"eighty":58.915911,"marketCap":12180979747},{"date":"2023-12-29","current":67.453032,"twenty":22.562873,"median":37.997597,"eighty":59.09156,"marketCap":12439013650},{"date":"2024-01-05","current":67.067035,"twenty":22.579121,"median":38.02395,"eighty":59.439201,"marketCap":12367831884},{"date":"2024-01-12","current":69.021146,"twenty":22.595368,"median":38.190507,"eighty":60.273538,"marketCap":12728189575},{"date":"2024-01-19","current":67.646031,"twenty":22.640362,"median":38.303178,"eighty":60.799389,"marketCap":12474604533},{"date":"2024-01-26","current":70.227388,"twenty":22.677856,"median":38.50491,"eighty":61.532363,"marketCap":12950632595},{"date":"2024-02-02","current":69.19002,"twenty":22.884075,"median":38.587304,"eighty":61.916597,"marketCap":12759331598},{"date":"2024-02-09","current":69.23827,"twenty":22.890324,"median":38.625868,"eighty":62.198957,"marketCap":12768229319},{"date":"2024-02-16","current":11.82036,"twenty":22.884075,"median":38.696427,"eighty":62.821129,"marketCap":13414146195},{"date":"2024-02-23","current":12.210042,"twenty":22.58287,"median":38.613793,"eighty":62.778472,"marketCap":13856370795},{"date":"2024-03-01","current":11.942381,"twenty":22.255419,"median":38.523621,"eighty":62.312727,"marketCap":13552620565},{"date":"2024-03-08","current":11.824296,"twenty":20.664972,"median":38.430545,"eighty":62.163037,"marketCap":13418613110},{"date":"2024-03-15","current":11.749508,"twenty":15.016671,"median":38.210102,"eighty":62.021864,"marketCap":13333741722},{"date":"2024-03-22","current":11.977807,"twenty":14.597006,"median":38.097431,"eighty":61.966617,"marketCap":13592822801},{"date":"2024-03-28","current":11.98568,"twenty":14.455899,"median":37.997597,"eighty":61.934385,"marketCap":13601756631},{"date":"2024-04-05","current":11.30472,"twenty":14.395746,"median":37.829562,"eighty":61.889111,"marketCap":12828980310},{"date":"2024-04-12","current":11.434614,"twenty":14.190992,"median":37.744722,"eighty":61.843383,"marketCap":12976388510},{"date":"2024-04-19","current":10.978016,"twenty":14.097435,"median":37.720229,"eighty":61.737288,"marketCap":12458226353},{"date":"2024-04-26","current":11.170864,"twenty":13.930103,"median":37.622254,"eighty":61.590913,"marketCap":12677076753},{"date":"2024-05-03","current":11.429173,"twenty":13.857739,"median":37.494887,"eighty":61.301823,"marketCap":12970214422},{"date":"2024-05-10","current":15.790439,"twenty":13.745111,"median":37.220558,"eighty":61.104216,"marketCap":12613939409},{"date":"2024-05-17","current":15.739176,"twenty":13.753736,"median":37.112786,"eighty":60.998094,"marketCap":12573351116},{"date":"2024-05-24","current":15.157707,"twenty":13.808268,"median":34.822839,"eighty":60.858379,"marketCap":12108840655},{"date":"2024-05-31","current":14.898022,"twenty":13.852118,"median":32.773769,"eighty":60.755916,"marketCap":11901389381},{"date":"2024-06-07","current":15.331469,"twenty":13.879102,"median":32.556622,"eighty":60.617519,"marketCap":12247651204},{"date":"2024-06-14","current":15.393723,"twenty":13.894843,"median":32.486824,"eighty":60.463826,"marketCap":12297383268},{"date":"2024-06-21","current":15.071134,"twenty":13.897092,"median":32.455803,"eighty":60.288176,"marketCap":12039680751},{"date":"2024-06-28","current":15.093772,"twenty":13.904805,"median":32.339474,"eighty":60.258901,"marketCap":12057765138},{"date":"2024-07-05","current":14.669312,"twenty":13.920951,"median":32.246411,"eighty":60.178394,"marketCap":11718682879},{"date":"2024-07-12","current":15.127728,"twenty":13.960618,"median":31.928445,"eighty":60.006404,"marketCap":12084891719},{"date":"2024-07-15","current":15.150366,"twenty":13.981981,"median":31.796605,"eighty":59.980789,"marketCap":12102976106},{"date":"2024-08-02","current":16.123793,"twenty":14.003344,"median":31.734563,"eighty":59.955173,"marketCap":12880604754},{"date":"2024-08-09","current":17.406437,"twenty":14.059562,"median":31.277002,"eighty":59.651445,"marketCap":11718640189},{"date":"2024-08-16","current":18.245141,"twenty":14.081953,"median":31.218837,"eighty":59.351376,"marketCap":12283285949},{"date":"2024-08-23","current":18.458146,"twenty":14.097435,"median":31.168428,"eighty":59.252573,"marketCap":12426688047},{"date":"2024-08-30","current":19.390039,"twenty":14.125705,"median":31.141285,"eighty":59.09156,"marketCap":13054072226},{"date":"2024-09-06","current":19.350101,"twenty":14.146138,"median":31.063732,"eighty":58.974461,"marketCap":13027184332},{"date":"2024-09-13","current":18.338331,"twenty":14.160754,"median":31.005568,"eighty":58.937867,"marketCap":12346024367},{"date":"2024-09-20","current":18.631211,"twenty":14.184848,"median":30.990057,"eighty":58.879317,"marketCap":12543202252},{"date":"2024-09-27","current":18.764339,"twenty":14.243506,"median":30.904749,"eighty":58.641458,"marketCap":12632828563},{"date":"2024-10-04","current":18.471458,"twenty":14.326324,"median":30.775014,"eighty":58.287732,"marketCap":12435650679},{"date":"2024-10-11","current":18.298392,"twenty":14.368253,"median":30.610049,"eighty":58.012489,"marketCap":12319136474},{"date":"2024-10-18","current":18.67115,"twenty":14.390686,"median":30.54413,"eighty":57.699824,"marketCap":12570090145},{"date":"2024-10-25","current":18.158608,"twenty":14.408114,"median":30.465593,"eighty":57.566941,"marketCap":12225028847},{"date":"2024-10-31","current":18.098701,"twenty":14.411846,"median":30.382231,"eighty":57.528884,"marketCap":12184697007},{"date":"2024-11-08","current":10.289745,"twenty":14.406989,"median":30.354125,"eighty":57.466826,"marketCap":11782880049},{"date":"2024-11-15","current":9.925026,"twenty":14.223393,"median":30.330859,"eighty":57.444951,"marketCap":11365236488},{"date":"2024-11-22","current":10.243185,"twenty":14.10977,"median":30.171876,"eighty":57.378974,"marketCap":11729563850},{"date":"2024-11-29","current":10.344065,"twenty":14.04607,"median":30.088852,"eighty":57.232599,"marketCap":11845082282},{"date":"2024-12-06","current":10.239305,"twenty":13.894281,"median":29.997383,"eighty":57.230825,"marketCap":11725120833},{"date":"2024-12-13","current":9.781466,"twenty":13.745303,"median":29.892686,"eighty":57.217798,"marketCap":11200844873},{"date":"2024-12-20","current":9.420627,"twenty":13.663787,"median":29.795746,"eighty":57.141115,"marketCap":10787644329},{"date":"2024-12-27","current":9.855186,"twenty":13.579288,"median":29.601864,"eighty":57.126477,"marketCap":11285262189},{"date":"2025-01-03","current":10.006506,"twenty":13.531271,"median":29.389187,"eighty":57.100862,"marketCap":11458539837},{"date":"2025-01-10","current":10.165586,"twenty":13.458029,"median":29.384716,"eighty":57.078905,"marketCap":11640703518},{"date":"2025-01-17","current":12.008583,"twenty":13.264639,"median":29.284382,"eighty":57.05329,"marketCap":13751136407},{"date":"2025-01-24","current":11.880543,"twenty":13.173566,"median":29.224184,"eighty":57.011305,"marketCap":13604516859},{"date":"2025-01-31","current":12.256903,"twenty":13.053885,"median":29.19859,"eighty":56.923371,"marketCap":14035489470},{"date":"2025-02-07","current":12.183183,"twenty":12.930518,"median":29.127468,"eighty":56.889499,"marketCap":13951072155},{"date":"2025-02-14","current":16.37486,"twenty":12.913057,"median":29.097649,"eighty":56.873866,"marketCap":14065726416},{"date":"2025-02-21","current":16.813743,"twenty":12.927331,"median":28.991567,"eighty":56.853021,"marketCap":14442719083},{"date":"2025-02-28","current":16.833921,"twenty":12.943264,"median":28.872386,"eighty":56.839993,"marketCap":14460052079},{"date":"2025-03-07","current":16.788519,"twenty":12.984673,"median":28.666911,"eighty":56.830068,"marketCap":14421052838},{"date":"2025-03-14","current":16.485842,"twenty":13.031997,"median":28.143472,"eighty":56.813938,"marketCap":14161057895},{"date":"2025-03-21","current":16.899501,"twenty":13.049744,"median":27.981993,"eighty":56.738584,"marketCap":14516384317},{"date":"2025-03-28","current":15.966245,"twenty":13.070449,"median":27.828632,"eighty":56.720287,"marketCap":13714733243},{"date":"2025-04-04","current":16.03687,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"marketCap":13775398729},{"date":"2025-04-11","current":15.744282,"twenty":13.135338,"median":27.489212,"eighty":56.683693,"marketCap":13524070285},{"date":"2025-04-17","current":16.238655,"twenty":13.157825,"median":27.373688,"eighty":56.63978,"marketCap":13948728691},{"date":"2025-04-25","current":16.157941,"twenty":13.203924,"median":27.227853,"eighty":56.610156,"marketCap":13879396707},{"date":"2025-05-02","current":16.384949,"twenty":13.220789,"median":27.175409,"eighty":56.605494,"marketCap":14074392914},{"date":"2025-05-09","current":13.13487,"twenty":13.220789,"median":27.160092,"eighty":56.580228,"marketCap":14343054355},{"date":"2025-05-16","current":12.773553,"twenty":13.130466,"median":27.076244,"eighty":56.544637,"marketCap":13955796159},{"date":"2025-05-23","current":12.461156,"twenty":13.066308,"median":26.904805,"eighty":56.28848,"marketCap":13614485927},{"date":"2025-05-30","current":12.588429,"twenty":12.968109,"median":26.873672,"eighty":56.212937,"marketCap":13753538244},{"date":"2025-06-06","current":13.016528,"twenty":12.90448,"median":26.797021,"eighty":56.195426,"marketCap":14221259673},{"date":"2025-06-13","current":13.602754,"twenty":12.90448,"median":26.668197,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-06-20","current":13.463911,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14710049635},{"date":"2025-06-27","current":13.602754,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-07-03","current":14.026996,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15325250795},{"date":"2025-07-11","current":13.930577,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15219908130},{"date":"2025-07-18","current":13.679889,"twenty":12.997415,"median":26.697563,"eighty":56.189678,"marketCap":14946017203},{"date":"2025-07-25","current":14.111845,"twenty":13.115975,"median":26.697563,"eighty":56.189678,"marketCap":15417952339},{"date":"2025-08-01","current":14.192836,"twenty":13.181814,"median":26.697563,"eighty":56.189678,"marketCap":15506440177},{"date":"2025-08-08","current":15.6743,"twenty":13.310592,"median":26.697563,"eighty":56.189678,"marketCap":15999165780},{"date":"2025-08-15","current":15.458307,"twenty":13.437714,"median":26.697563,"eighty":56.189678,"marketCap":15778696325},{"date":"2025-08-22","current":15.37784,"twenty":13.501317,"median":26.697563,"eighty":56.189678,"marketCap":15696560645},{"date":"2025-08-29","current":15.085614,"twenty":13.602754,"median":26.697563,"eighty":56.189678,"marketCap":15398278441},{"date":"2025-09-05","current":15.627714,"twenty":13.682974,"median":26.726929,"eighty":56.189678,"marketCap":15951613545},{"date":"2025-09-12","current":15.54301,"twenty":13.727713,"median":26.697563,"eighty":56.189678,"marketCap":15865154935},{"date":"2025-09-19","current":15.132201,"twenty":13.827216,"median":26.697563,"eighty":56.189678,"marketCap":15445830676},{"date":"2025-09-26","current":14.780683,"twenty":13.857345,"median":26.697563,"eighty":56.189678,"marketCap":15087027445},{"date":"2025-10-03","current":15.454072,"twenty":13.907401,"median":26.697563,"eighty":56.189678,"marketCap":15774373394},{"date":"2025-10-10","current":15.305842,"twenty":13.996913,"median":26.697563,"eighty":56.189678,"marketCap":15623070827},{"date":"2025-10-17","current":15.390545,"twenty":14.093333,"median":26.697563,"eighty":56.189678,"marketCap":15709529437},{"date":"2025-10-24","current":15.606538,"twenty":14.18067,"median":26.697563,"eighty":56.189678,"marketCap":15929998892},{"date":"2025-10-31","current":15.644654,"twenty":14.376689,"median":26.697563,"eighty":56.189678,"marketCap":15968905267},{"date":"2025-11-07","current":22.776673,"twenty":14.487757,"median":26.697563,"eighty":56.189678,"marketCap":17423152601},{"date":"2025-11-14","current":22.190221,"twenty":14.585763,"median":26.697563,"eighty":56.189678,"marketCap":16974542737},{"date":"2025-11-21","current":21.441797,"twenty":14.71386,"median":26.697563,"eighty":56.189678,"marketCap":16402031102},{"date":"2025-11-28","current":22.352193,"twenty":14.852999,"median":26.697563,"eighty":56.189678,"marketCap":17098444509},{"date":"2025-12-05","current":21.866276,"twenty":14.925958,"median":26.697563,"eighty":56.189678,"marketCap":16726739194},{"date":"2025-12-12","current":21.676378,"twenty":15.032381,"median":26.697563,"eighty":56.189678,"marketCap":16581475048},{"date":"2025-12-19","current":21.464138,"twenty":15.093897,"median":26.697563,"eighty":56.189678,"marketCap":16419121002},{"date":"2025-12-26","current":21.922129,"twenty":15.149631,"median":26.697563,"eighty":56.189678,"marketCap":16769463943},{"date":"2026-01-02","current":21.581428,"twenty":15.187258,"median":26.697563,"eighty":56.189678,"marketCap":16508842974},{"date":"2026-01-09","current":22.48624,"twenty":15.23808,"median":26.697563,"eighty":56.189678,"marketCap":17200983907},{"date":"2026-01-16","current":22.184636,"twenty":15.252479,"median":26.697563,"eighty":56.189678,"marketCap":16970270263},{"date":"2026-01-23","current":22.402461,"twenty":15.277931,"median":26.697563,"eighty":56.189678,"marketCap":17136896783},{"date":"2026-01-30","current":22.821355,"twenty":15.310924,"median":26.697563,"eighty":56.189678,"marketCap":17457332400},{"date":"2026-02-06","current":24.630978,"twenty":15.328798,"median":26.697563,"eighty":56.189678,"marketCap":18841614264},{"date":"2026-02-13","current":24.895555,"twenty":15.360052,"median":26.697563,"eighty":56.189678,"marketCap":19193153817},{"date":"2026-02-20","current":25.067824,"twenty":15.379534,"median":26.630837,"eighty":56.189678,"marketCap":19325963587},{"date":"2026-02-27","current":25.20675,"twenty":15.379534,"median":26.529015,"eighty":56.189678,"marketCap":19433068240},{"date":"2026-03-06","current":25.384575,"twenty":15.379534,"median":26.382064,"eighty":56.189678,"marketCap":19570162196},{"date":"2026-03-13","current":25.490159,"twenty":15.379534,"median":26.335729,"eighty":56.189678,"marketCap":19651561732},{"date":"2026-03-20","current":25.30122,"twenty":15.379534,"median":26.159501,"eighty":56.189678,"marketCap":19505899404},{"date":"2026-03-27","current":26.084763,"twenty":15.379534,"median":26.077607,"eighty":56.189678,"marketCap":20109969647}],"updateTime":1774742942564},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RPRX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2595422753","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595422753","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595422753?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:59","pubTimestamp":1767045545,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments, reported a disposal of common shares of Royalty Pharma plc, according to a recent regulatory filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL76rFWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2595753935","title":"Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2595753935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595753935?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:40","pubTimestamp":1767044400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA2GZPJ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2595975812","title":"PTC Therapeutics Sells Remaining Royalty Interest in Evrysdi to Royalty Pharma for $240 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2595975812","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595975812?lang=en_us&edition=fundamental","pubTime":"2025-12-30 05:06","pubTimestamp":1767042370,"startTime":"0","endTime":"0","summary":"PTC Therapeutics, Inc. announced it has entered into an amendment to its royalty purchase agreement with Royalty Pharma Investments 2019 ICAV. Under the terms of the amendment, PTC sold its remaining interest in royalties related to Roche's Evrysdi  to Royalty Pharma for $240 million in upfront cash. The agreement also includes provisions for three potential additional payments of $20 million each, contingent on certain sales-based royalty payment thresholds being met in 2027, 2028, and 2029. Following this transaction, Royalty Pharma now owns 100% of the royalty interest, and PTC Therapeutics retains no further royalty rights under the agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the origin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL9kVSJ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","RPRX","BK4007","LU0320765992.SGD","LU0889565916.HKD","PTCT"],"gpt_icon":0},{"id":"2593458611","title":"EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593458611","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593458611?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:10","pubTimestamp":1766437813,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments at Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL6vRPBj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"EVP Marshall Urist Reports Disposal of Royalty Pharma plc Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2592594930","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592594930","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592594930?lang=en_us&edition=fundamental","pubTime":"2025-12-18 06:43","pubTimestamp":1766011424,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL58wjjC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2592798953","title":"How Investors Are Reacting To Royalty Pharma (RPRX) Expanding Oncology Royalties With Nuvalent Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2592798953","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592798953?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:24","pubTimestamp":1765920253,"startTime":"0","endTime":"0","summary":"Royalty Pharma recently acquired a pre-existing royalty interest in Nuvalent’s cancer drug candidates neladalkib and zidesamtinib for up to US$315,000,000, securing potential royalty streams through about 2041–2042.\nThis move broadens Royalty Pharma’s exposure to next-generation lung cancer treatments targeting ALK and ROS1 mutations, underscoring its focus on late-stage oncology innovation.\nWe’ll now examine how this oncology-focused royalty acquisition could influence Royalty Pharma’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-investors-are-reacting-to-royalty-pharma-rprx-expanding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-investors-are-reacting-to-royalty-pharma-rprx-expanding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4539","BK4211","BK4139","ISBC","RPRX","NUVL"],"gpt_icon":0},{"id":"2591981376","title":"Royalty Pharma  - Buys Low-Single Digit Royalty on Neladalkib and Zidesamtinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981376","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981376?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:15","pubTimestamp":1765887300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9P0VT1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX","BK4139","NUVL","BK4539"],"gpt_icon":0},{"id":"2591327981","title":"Royalty Pharma  - Royalty Duration for Both Therapies Extends Through 2041 to 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2591327981","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591327981?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:15","pubTimestamp":1765887300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA9P0VT1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4139","BK4539","NUVL","BK4007"],"gpt_icon":0},{"id":"2591697637","title":"Royalty Pharma (RPRX): Revisiting Valuation After Fresh Analyst Upgrades and Strengthening Buy-Side Consensus","url":"https://stock-news.laohu8.com/highlight/detail?id=2591697637","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591697637?lang=en_us&edition=fundamental","pubTime":"2025-12-15 11:24","pubTimestamp":1765769067,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) is back in focus after TD Cowen reaffirmed its buy rating and lifted expectations, adding to a string of upbeat calls from other major firms that are steadily reshaping sentiment.\nSee our latest analysis for Royalty Pharma.\nDespite a softer patch in the last week, with a negative 7 day share price return, Royalty Pharma’s roughly 49 percent year to date share price return and 58 percent one year total shareholder return show that momentum is still firmly building behind...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/royalty-pharma-rprx-revisiting-valuation-after-fresh-analyst","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/royalty-pharma-rprx-revisiting-valuation-after-fresh-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RPRX"],"gpt_icon":0},{"id":"2590006599","title":"Royalty Pharma  : TD Cowen Raises Target Price to $45 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2590006599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590006599?lang=en_us&edition=fundamental","pubTime":"2025-12-11 17:38","pubTimestamp":1765445928,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH0CY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2589483988","title":"EVP, Investments & CLO George W. Lloyd Reports Disposal of Royalty Pharma plc Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589483988","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589483988?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:02","pubTimestamp":1764972142,"startTime":"0","endTime":"0","summary":"George W. Lloyd, EVP, Investments & CLO of Royalty Pharma plc, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2HhWrX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"EVP, Investments & CLO George W. Lloyd Reports Disposal of Royalty Pharma plc Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2589981924","title":"Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start","url":"https://stock-news.laohu8.com/highlight/detail?id=2589981924","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589981924?lang=en_us&edition=fundamental","pubTime":"2025-12-06 00:49","pubTimestamp":1764953340,"startTime":"0","endTime":"0","summary":"FDA placed hold on Denali's drug for Pompe disease, requesting changes to protocol. No additional studies requested. Minimal delays expected.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/05/FDA.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/05/FDA.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/12/49235359/denali-flags-minimal-delay-after-fda-halts-rare-disease-trial-start","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/12/49235359/denali-flags-minimal-delay-after-fda-halts-rare-disease-trial-start","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4535","BK4139","DNLI","IND","RPRX","BK4007","BK4548"],"gpt_icon":0},{"id":"2588488474","title":"Denali Therapeutics, Royalty Pharma Enter $275 Million Royalty Funding Agreement for Hunter Syndrome Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2588488474","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588488474?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:06","pubTimestamp":1764853560,"startTime":"0","endTime":"0","summary":"Denali Therapeutics and Royalty Pharma entered a $275 million royalty funding agreement based on future sales of tividenofusp alfa.The companies said Thursday that the agreement is subject to various closing conditions. These include Denali receiving accelerated approval from the U.S. Food and Drug Administration for the treatment. A biologics license application for the accelerated approval of the treatment is currently under review by the FDA.Under the deal, Royalty Pharma would make an initial $200 million payment at the closing, as well as an additional $75 million payment if the treatment is approved by the European Medicines Agency by Dec. 31, 2029.In exchange, Royalty Pharma will receive a 9.25% royalty on worldwide net sales of tividenofusp alfa from Denali.The royalty payments would cease upon reaching a 3x multiple, or 2.5x multiple if achieved by the first quarter of 2039, the companies said.Royalty Pharma Chief Executive Pablo Legorreta said the company is \"thrilled to esta","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4548","DNLI","LENZ","BK4007","BK4139","RPRX","BK4539"],"gpt_icon":0},{"id":"2588288964","title":"Denali Therapeutics Inc - Royalty Pharma to Receive 9.25% Royalty on Worldwide Sales of Tividenofusp Alfa From Denali","url":"https://stock-news.laohu8.com/highlight/detail?id=2588288964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588288964?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:00","pubTimestamp":1764849601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nTUA30ZTCF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","BK4535","BK4007","DNLI","BK4548","BK4139"],"gpt_icon":0},{"id":"2588022262","title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588022262","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588022262?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:11","pubTimestamp":1764799863,"startTime":"0","endTime":"0","summary":"Marshall Urist, EVP, Research & Investments, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLg6LxJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2587675442","title":"Will Raised 2025 Guidance and CFO Share Sale Shift Royalty Pharma's (RPRX) Growth Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587675442","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587675442?lang=en_us&edition=fundamental","pubTime":"2025-11-29 11:18","pubTimestamp":1764386314,"startTime":"0","endTime":"0","summary":"Royalty Pharma recently reported a strong third quarter, with portfolio receipts rising by 11% to US$814 million and updated its full-year guidance for 2025 to reflect further growth, following the announcement by the company that its CFO sold US$2.68 million in shares through a pre-arranged plan.\nAn interesting insight is that while short interest in Royalty Pharma’s stock increased, it remains below the industry average, pointing to relatively lower bearish sentiment from investors...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/will-raised-2025-guidance-and-cfo-share-sale-shift-royalty-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/will-raised-2025-guidance-and-cfo-share-sale-shift-royalty-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2586293337","title":"Royalty Pharma CFO Terrance P. Coyne Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586293337","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586293337?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:02","pubTimestamp":1764194542,"startTime":"0","endTime":"0","summary":"Terrance P. Coyne, EVP & CFO of Royalty Pharma plc, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL8C37VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Royalty Pharma CFO Terrance P. Coyne Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2586343257","title":"Royalty Pharma to Present at Citi and Evercore Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586343257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586343257?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:15","pubTimestamp":1764162909,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has announced its participation in two upcoming investor conferences in December. The company will present at Citi's 2025 Global Healthcare Conference on December 2 at 3:15 p.m. ET and at Evercore's 8th Annual Healthcare Conference on December 3 at 3:50 p.m. ET. Webcasts of the presentations will be available on Royalty Pharma's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire  on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL4dWHx9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4127","BK4588","EVR","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","BK4007","RPRX","BK4585","IE00B64PRP62.GBP","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2585129847","title":"Royalty Pharma EVP George W. Lloyd Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585129847","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585129847?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:56","pubTimestamp":1763762216,"startTime":"0","endTime":"0","summary":"George W. Lloyd, EVP, Investments & CLO of Royalty Pharma plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL4W7fb0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Royalty Pharma EVP George W. Lloyd Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2582806891","title":"Royalty Pharma plc Publishes Transcript of Q3 2025 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2582806891","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582806891?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:03","pubTimestamp":1762794226,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has published the transcript of its third-quarter 2025 earnings call, held on November 5, 2025. The event brought together key executives, including the Chief Executive Officer, Chief Financial Officer, and other senior leadership, as well as analysts from firms such as Goldman Sachs, JPMorgan Chase, Citibank, and Evercore ISI. During the call, management reviewed the company's Q3 2025 financial results and discussed forward-looking statements, highlighting both recent achievements and ongoing strategic priorities. The Senior Vice President, Head of Investor Relations & Communications, opened the call by thanking participants and referring listeners to the earnings results and presentation slides available on the company's website. Management reminded participants that, \"information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL252ylx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU1244550494.USD","LU2750360641.GBP","LU2360032135.SGD","LU1974910355.USD","LU0162691827.USD","LU0345769128.USD","LU1868836914.USD","LU1720051017.SGD","LU0130102774.USD","LU0820561818.USD","LU1868836591.USD","BK4516","LU0345769631.USD","LU0345770993.USD","LU0787776722.HKD","RPRX","LU1670627923.USD","LU2264538146.SGD","LU2430703095.HKD","SG9999002232.USD","LU0417517546.SGD","LU0310799852.SGD","LU2462157665.USD","LU2471134796.USD","LU0820561909.HKD","LU2750360997.AUD","LU2417539215.USD","SG9999002224.SGD","LU0208291251.USD","BK4588","LU0345770308.USD","IE00B19Z3581.USD","LU0648001328.SGD","LU0496365809.HKD","LU1868837136.USD","IE00BHPRN162.USD","BK4504","LU1244550221.USD","LU2471134879.HKD","IE00BJLML261.HKD","EVR","LU0882574139.USD","IE00BKVL7J92.USD","LU0976567544.SGD","LU0106261372.USD","LU0868494708.USD","LU0320765646.SGD","LU0149725797.USD","IE00BYXW3230.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":97,"code":"91000000","status":"200"}]}}